Global Immunotherapy Drugs Market to reach USD 338.4 billion by 2027.

Global Immunotherapy Drugs Market Size study with COVID-19 Impact, by Type (Monoclonal Antibodies, Checkpoint Inhibitors, Interferons & Interleukins and Other Immunotherapies), by Therapeutic Area (Cancer, Autoimmune & Inflammatory Diseases, Infectious Diseases and Others), by End-User (Hospitals, Clinics and Others) and Regional Forecasts 2020-2027
Product Code:  HALDAT_92610763
Chapter 1.	Executive Summary 
1.1.	Market Snapshot
1.2.	Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1.	Immunotherapy Drugs Market, by Region, 2018-2027 (USD Billion)
1.2.2.	Immunotherapy Drugs Market, by Type, 2018-2027 (USD Billion)
1.2.3.	Immunotherapy Drugs Market, by Therapeutic Area, 2018-2027 (USD Billion)
1.2.4.	Immunotherapy Drugs Market, by End-User, 2018-2027 (USD Billion)
1.3.	Key Trends
1.4.	Estimation Methodology
1.5.	Research Assumption
Chapter 2.	Global Immunotherapy Drugs Market Definition and Scope 
2.1.	Objective of the Study
2.2.	Market Definition & Scope
2.2.1.	Scope of the Study
2.2.2.	Industry Evolution
2.3.	Years Considered for the Study
2.4.	Currency Conversion Rates
Chapter 3.	Global Immunotherapy Drugs Market Dynamics	
3.1.	Immunotherapy Drugs Market Impact Analysis (2018-2027)
3.1.1.	Market Drivers
3.1.2.	Market Challenges
3.1.3.	Market Opportunities
Chapter 4.	Global Immunotherapy Drugs Market Industry Analysis
4.1.	Porter’s 5 Force Model
4.1.1.	Bargaining Power of Suppliers
4.1.2.	Bargaining Power of Buyers
4.1.3.	Threat of New Entrants
4.1.4.	Threat of Substitutes
4.1.5.	Competitive Rivalry
4.1.6.	Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2.	PEST Analysis
4.2.1.	Political 
4.2.2.	Economical
4.2.3.	Social 
4.2.4.	Technological 
4.3.	Investment Adoption Model
4.4.	Analyst Recommendation & Conclusion
Chapter 5.	Global Immunotherapy Drugs Market, by Type          
5.1.	Market Snapshot 
5.2.	Global Immunotherapy Drugs Market by Type, Performance - Potential Analysis
5.3.	Global Immunotherapy Drugs Market Estimates & Forecasts by Type 2017-2027 (USD Billion)
5.4.	Immunotherapy Drugs Market, Sub Segment Analysis
5.4.1.	 Monoclonal Antibodies
5.4.2.	Checkpoint Inhibitors
5.4.3.	Interferons & Interleukins
5.4.4.	Other Immunotherapies
Chapter 6.	Global Immunotherapy Drugs Market, by Therapeutic Area          
6.1.	Market Snapshot 
6.2.	Global Immunotherapy Drugs Market by Therapeutic Area, Performance - Potential Analysis
6.3.	Global Immunotherapy Drugs Market Estimates & Forecasts by Therapeutic Area 2017-2027 (USD Billion)
6.3.1.	Cancer
6.3.2.	Autoimmune & Inflammatory Diseases
6.3.3.	Infectious Diseases
6.3.4.	Others
Chapter 7.	Global Immunotherapy Drugs Market, by End-User          
7.1.	Market Snapshot 
7.2.	Global Immunotherapy Drugs Market by End-User, Performance - Potential Analysis
7.3.	Global Immunotherapy Drugs Market Estimates & Forecasts by End-User 2017-2027 (USD Billion)
7.4.	Immunotherapy Drugs Market, Sub Segment Analysis
7.4.1.	 Hospitals
7.4.2.	Clinics
7.4.3.	Others
Chapter 8.	Global Immunotherapy Drugs Market, Regional Analysis
8.1.	Immunotherapy Drugs Market, Regional Market Snapshot 
8.2.	North America Immunotherapy Drugs Market 
8.2.1.1.	U.S. Immunotherapy Drugs Market 
8.2.1.2.	Type breakdown estimates & forecasts, 2017-2027
8.2.1.3.	Therapeutic Area breakdown estimates & forecasts, 2017-2027
8.2.1.4.	End-User breakdown estimates & forecasts, 2017-2027
8.2.2.	Canada Immunotherapy Drugs Market
8.3.	Europe Immunotherapy Drugs Market Snapshot
8.3.1.	U.K. Immunotherapy Drugs Market 
8.3.2.	Germany Immunotherapy Drugs Market
8.3.3.	France Immunotherapy Drugs Market
8.3.4.	Spain Immunotherapy Drugs Market
8.3.5.	Italy Immunotherapy Drugs Market
8.3.6.	Rest of Europe Immunotherapy Drugs Market
8.4.	Asia-Pacific Immunotherapy Drugs Market Snapshot
8.4.1.	China Immunotherapy Drugs Market 
8.4.2.	India Immunotherapy Drugs Market 
8.4.3.	Japan Immunotherapy Drugs Market
8.4.4.	Australia Immunotherapy Drugs Market
8.4.5.	South Korea Immunotherapy Drugs Market
8.4.6.	Rest of Asia Pacific Immunotherapy Drugs Market
8.5.	Latin America Immunotherapy Drugs Market Snapshot
8.5.1.	Brazil Immunotherapy Drugs Market
8.5.2.	Mexico Immunotherapy Drugs Market
8.6.	Rest of The World Immunotherapy Drugs Market

Chapter 9.	Competitive Intelligence
9.1.	Top Market Strategies
9.2.	Company Profiles
9.2.1.	Roche Holding AG 
9.2.1.1.	Key Information
9.2.1.2.	Overview
9.2.1.3.	Financial (Subject to Data Availability)
9.2.1.4.	Product Summary
9.2.1.5.	Recent Developments
9.2.2.	 Pfizer Inc.
9.2.3.	Merck & Co., Inc.
9.2.4.	Novartis International AG
9.2.5.	Johnson & Johnson
9.2.6.	Sanofi S.A. 
9.2.7.	GlaxoSmithKline plc 
9.2.8.	AbbVie Inc.
9.2.9.	Amgen Inc.
9.2.10.	C.H. Boehringer Sohn AG & Co.. KG 
Chapter 10.	Research Process
10.1.	Research Process
10.1.1.	Data Mining
10.1.2.	Analysis
10.1.3.	Market Estimation
10.1.4.	Validation
10.1.5.	Publishing
10.2.	Research Attributes
10.3.	Research Assumption

Global Immunotherapy Drugs Market is valued approximately USD 146.8 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 11 % over the forecast period 2020-2027. Immunotherapy drugs are used to enhance the immunity of human body, the drug stimulates the immune system of the body and generate an immune response aiding the production of antibodies that are produced against antigen to kill the cancerous or tumor cells. Immunotherapy Drugs is being highly demanded for enhancing the immune system during the coronavirus pandemic across the world. Furthermore, cancer immunotherapy community is poised to contribute to the current fight against COVID-19. The increasing adoption of immunotherapy drugs over conventional treatment regimens, rising prevalence of cancer and autoimmune & infectious diseases and increasing demand for monoclonal antibodies and biosimilars are the few factors responsible for growth of the market over the forecast period. For instance: as per American Cancer Society, more than 15.5 million cancer cases were reported in January 2016. Later 1.7 million new cases diagnosed in 2018 at U.S. Moreover, the rising advancements in immunotherapy drugs and other strategic alliance by market key players will create a lucrative demand for this market. For instance: in April 2018, Europe based Roche Holdings AG launched monoclonal antibody atezolizumab used for the treatment of small cell lung cancer in India. Whereas, timeline issues, side-effects, and manufacturing complexities are the major factors restraining the growth of global Immunotherapy Drugs market during the forecast period.

The regional analysis of global Immunotherapy Drugs market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world owing to the increasing prevalence of cancer and autoimmune diseases, rising demand for safer cancer therapies, increasing number of approvals from the FDA, and the introduction of favorable reimbursement policies. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027.

Major market player included in this report are:
Roche Holding AG
Pfizer Inc.
Merck & Co., Inc.
Novartis International AG
Johnson & Johnson
Sanofi S.A.
GlaxoSmithKline plc
AbbVie Inc.
Amgen Inc.
C.H. Boehringer Sohn AG & Co.. KG

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

by Type:
Monoclonal Antibodies
Checkpoint Inhibitors
Interferons & Interleukins
Other Immunotherapies

by Therapeutic Area:
Cancer
Autoimmune & Inflammatory Diseases
Infectious Diseases
Others

By End-User:
Hospitals
Clinics
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global Immunotherapy Drugs Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.



Loading…